As the first and only device of its kind, the Carpentier-Edwards PERIMOUNT Magna aortic heart valve combines more than 20 years of clinical experience and innovation with the most advanced tissue engineering technologies. It was designed on the foundation of Edwards' original PERIMOUNT pericardial valves, the most widely implanted tissue heart valves globally. Today, the PERIMOUNT Magna valve is the best selling tissue valve in the world.
The PERIMOUNT Magna pericardial valve was created specifically to optimize blood flow for the patient. The valve's unique design facilitates placement above the patient's native valve opening, and its streamlined sewing ring supports improved performance by enabling an increase in the size of the valve. To target calcification—one of the primary causes of tissue valve deterioration—the leaflets of the PERIMOUNT Magna valve are treated with the Carpentier-Edwards ThermaFix* process.
Hemodynamic Performance
- The PERIMOUNT Magna valve provides the largest effective orifice area of any stented tissue valve, which optimizes blood flow for the patient.
- True supra-annular design facilitates placement above the patient's native valve opening, enabling improved hemodynamic performance.
Tissue Treatment
- Available with ThermaFix*, an anti-calcification technology.
- Only the ThermaFix* advanced tissue process has shown in laboratory studies that it extracts both major binding sites for calcium that lead to tissue calcification. Other tissue treatments may extract or coat only one of these two calcium binding sites.
- No clinical data are available which evaluate the long-term impact of the Edwards tissue treatment in patients.
